Legislation
SECTION 6830
Standardized patient-centered data elements
Education (EDN) CHAPTER 16, TITLE 8, ARTICLE 137
§ 6830. Standardized patient-centered data elements. 1. The
commissioner shall develop rules and regulations requiring standardized
patient-centered data elements consistent with existing technology and
equipment to be used on all prescription medicine dispensed to patients
in this state.
2. When developing the requirements for patient-centered data elements
on prescription drug labels, the commissioner shall consider:
(a) medical literacy research that identifies factors that improve
understandability of labels and promotes increased compliance with a
drug's intended use;
(b) factors that improve the clarity of directions for use;
(c) font types and sizes;
(d) inclusion of only patient-centered information; and
(e) the needs of special populations.
To ensure public input, the commissioner shall solicit input from the
state board of pharmacy and the state board of medicine, consumer
groups, advocates for special populations, pharmacists, physicians,
other health care professionals authorized to prescribe, and other
interested parties.
commissioner shall develop rules and regulations requiring standardized
patient-centered data elements consistent with existing technology and
equipment to be used on all prescription medicine dispensed to patients
in this state.
2. When developing the requirements for patient-centered data elements
on prescription drug labels, the commissioner shall consider:
(a) medical literacy research that identifies factors that improve
understandability of labels and promotes increased compliance with a
drug's intended use;
(b) factors that improve the clarity of directions for use;
(c) font types and sizes;
(d) inclusion of only patient-centered information; and
(e) the needs of special populations.
To ensure public input, the commissioner shall solicit input from the
state board of pharmacy and the state board of medicine, consumer
groups, advocates for special populations, pharmacists, physicians,
other health care professionals authorized to prescribe, and other
interested parties.